
|Articles|August 3, 2022
H1 and Lokavant Announce Partnership
Advertisement
H1 and Lokavant announced a data-and-analytics collaboration to bring enhanced automated intelligence to drug development. As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators to supplement H1’s existing Trial Landscape clinical trial repository.
Read more about the new partnership
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Needs to Be True Across Sponsors, Sites, and Regulators for Operation TrialBlazer to Succeed
2
ACT Brief: Trial Failures as Administrative Problems, CRO Consolidation for Global Trial Reach, and FDA Approval of First FOP Treatment
3
Curavit Acquires Lindus Health Clinical Research Organization Assets to Expand US and European Trial Operations
4
When the Slack Runs Out: AI and the CRO Operating Model
5




